<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
"http://www.w3.org/TR/html4/strict.dtd">
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>

	<!-- Basic Page Needs
  ================================================== -->
    <script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/jquery-1.8.3.min.js" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
	MathJax.Hub.Config({
	  "HTML-CSS": { linebreaks: { automatic: true } },
	         SVG: { linebreaks: { automatic: true } }
	});
	</script>
    <script type="text/javascript" src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
	<meta charset="utf-8">
	<title>Respiration &amp; Airways</title>
	<meta name="description" content="Course Notes for Respiration &amp; Airways">
	<meta name="author" content="Kevan Lu">
	<meta name="robots" content="noindex,nofollow"/>
	
	<!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">

	<!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/layout.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/content.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/print.css">	
	
	<script>
		(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
		(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
		m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
		})(window,document,'script','http://www.google-analytics.com/analytics.js','ga');		
		ga('create', 'UA-40381402-3', 'dropboxusercontent.com');
		ga('send', 'pageview');
	</script>

	<!-- Favicons
	================================================== -->
	<link rel="shortcut icon" href="https://dl.dropboxusercontent.com/u/157117/Class%20References/favicon.png" type="image/png">
</head>
<body>
    <div class="overlay"><h1><a style="border:none;" href="http://kevanlu.github.io/respirology//index.html">Skin Week</a></h1></div>
    <div class="sidebar-background"></div>
    <div class="sidebar">
        <!-- Displays a Search Bar-->
<form class="search" action="http://kevanlu.github.io/respirology/search.html">
<div style="float: left;"><input type="text" value="Search Course Notes" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
<div style="float: left;"><input type="button" id="tipue_search_button" onclick="this.form.submit();"></div>
<div style="clear: left;"></div>
</form>
<div class="search">
	<a class="main-link" href="http://kevanlu.github.io/respirology//index.html"><h5>Respiration &amp; Airways<h5></a>
</div>
        <nav>	
	<div class="sidebar">
		<ul class="navigation group">
			<li class="week"><strong>Week 1</strong></li>
			<ul>
				<li class="day">Monday, February 24</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/24/intro-respiratory-physiology.html">Introduction to Respiratory Physiology</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/24/lung-volumes-ventilation.html">Lung Volumes &amp; Ventilation</a></li></ul>
				<li class="day">Tuesday, February 25</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/25/breathing-control.html">Control of Breathing</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/25/pleura-lungs-anatomy-lab.html">Pleura &amp; Lungs Anatomy Lab</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/25/respiratory-pathology-il.html">Respiratory Pathology Independent Learning</a></li></ul>
				<li class="day">Wednesday, February 26</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/26/pulmonary-circulation.html">Pulmonary Circulation</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/26/gas-diffusion-transport.html">Gas Diffusion &amp; Transport</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/26/respiratory-pathology-histology.html">Respiratory Pathology &amp; Basic Histology</a></li></ul>
				<li class="day">Thursday, February 27</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/27/obstructive-diseases-1.html">Obstructive Lung Diseases I</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/27/obstructive-diseases-2.html">Obstructive Lung Diseases II</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/27/smoking-cessation-interventions.html">Smoking Cessation Interventions</a></li></ul>
				<li class="day">Friday, February 28</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/28/pulmonary-function-testing.html">Pulmonary Function Testing</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/28/pneumonia-tuberculosis.html">Pneumonia &amp; Tuberculosis</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/02/28/respiratory-physiology-case-review.html">Respiratory Physiology Case Review</a></li></ul>
			</ul>
			<li class="week"><strong>Week 2</strong></li>
			<ul>
				<li class="day">Monday, March 3</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/03/mechanics-respiration.html">Mechanics of Respiration</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/03/ventilation-perfusion-physiology.html">Physiology of Ventilation &amp; Perfusion</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/03/head-neck-anatomy-1.html">Head &amp; Neck Anatomy I</a></li></ul>
				<li class="day">Tuesday, March 4</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/04/thoracic-radiology-1.html">Thoracic Radiology I</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/04/thoracic-radiology-2.html">Thoracic Radiology II</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/04/pediatric-asthma-cystic-fibrosis.html">Paediatric Asthma &amp; Cystic Fibrosis</a></li></ul>
				<li class="day">Wednesday, March 5</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/05/cough-wheeze-child-small-group.html">Cough &amp; Wheeze Pediatric Small Group</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/05/clinical-aspects-pathology-interstitial-lung-diseases.html">Clinical Aspects &amp; Pathology of Diffuse Interstitial Lung Diseases</a></li></ul>
				<li class="day">Thursday, March 6</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/06/respiratory-medicine-small-group.html">Respirology Small Group Cases 7-10</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/06/head-neck-anatomy-2.html">Head &amp; Neck Anatomy II</a></li></ul>
				<li class="day">Friday, March 7</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/07/respiratory-failure.html">Respiratory Failure</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/07/pathology-obstructive-lung-diseases.html">Pathology of Obstructive Lung Diseases</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/07/pneumonia-pulmonary-infections-small-group.html">Pneumonia &amp; Pulmonary Infections Small Group Session</a></li></ul>
			</ul>
			<li class="week"><strong>Week 3</strong></li>
			<ul>
				<li class="day">Monday, March 17</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/17/sleep-disordered-breathing-case.html">Sleep Disordered Breathing</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/17/surgery-treatment-osa.html">Surgery in Treatment of Obstructive Sleep Apnea</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/17/pleural-disease.html">Pleural Disease</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/17/pulmonary-thromboembolism.html">Pulmonary Thromboembolism</a></li></ul>
				<li class="day">Tuesday, March 18</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/18/clinical-aspects-pathology-respiratory-neoplasms.html">Respiratory Neoplastic Diseases</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/18/neoplastic-non-neoplastic-small-group.html">Neoplastic &amp; Non-Neoplastic Lung Disease Small Group</a></li></ul>
				<li class="day">Wednesday, March 19</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/19/respiratory-medicine-small-group.html">Respirology Small Group Cases 11-14</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/19/blood-gas-analysis.html">Blood Gas Analysis</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/19/common-respiratory-airway-problems-family-medicine.html">Common Respiratory &amp; Airways Problems in Family Medicine</a></li></ul>
				<li class="day">Thursday, March 20</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/20/genetics-craniofacial-abnormalities.html">Genetics of Craniofacial Abnormalities</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/20/palliative-respiratory-failure.html">Palliative Care for Patients Dying with Respiratory Failure</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/20/respiratory-medicine-small-group.html">Respirology Small Group Cases 15-19</a></li></ul>
				<li class="day">Friday, March 21</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/21/pulmonary-hypertension.html">Pulmonary Hypertension</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/21/weekly-wrapup.html">Weekly Wrap-up &amp; Case of the Week</a></li></ul>
			</ul>
			<li class="week"><strong>Week 4</strong></li>
			<ul>
				<li class="day">Tuesday, March 25</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/25/physiology-clinical-aspects-hoarseness.html">Physiology &amp; Clinical Aspects of Hoarseness</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/25/anatomy-lab-larynx.html">Larynx Anatomy Lab</a></li></ul>
				<li class="day">Wednesday, March 26</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/26/upper-airway-management.html">Management of the Upper Airway</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/26/facial-trauma.html">Facial Trauma</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/26/anatomy-lab-face.html">Face Anatomy Lab</a></li></ul>
				<li class="day">Thursday, March 27</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/27/deep-neck-space-infections.html">Deep Neck Space Infections</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/27/thyroid.html">The Thyroid</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/27/anatomy-lab-neck.html">Neck Anatomy Lab</a></li></ul>
				<li class="day">Friday, March 28</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/28/pediatric-head-neck-masses.html">Pediatric Head &amp; Neck Masses</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/28/cleft-lip-palate.html">Cleft Lip &amp; Palate</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/28/anatomy-lab-mouth-tongue.html">Mouth &amp; Tongue Anatomy Lab</a></li></ul>
			</ul>
			<li class="week"><strong>Week 5</strong></li>
			<ul>
				<li class="day">Monday, March 31</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/31/pediatric-airway-stridor.html">Pediatric Airway &amp; Stridor</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/03/31/dentistry-medical-students.html">Dentistry for Medical Students</a></li></ul>
				<li class="day">Tuesday, April 1</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/01/nasal-obstruction-sinusitis-epistaxis.html">Nasal Obstruction, Sinusitis, Epistaxis</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/01/epistaxis.html">Epistaxis</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/01/anatomy-lab-nose-sinus.html">Nose &amp; Sinus Anatomy Lab</a></li></ul>
				<li class="day">Wednesday, April 2</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/02/endoscopy-upper-aerodigestive-tract.html">Endoscopy of the Upper Aerodigestive Tract</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/02/pharyngitis-adenotonsillar-disease.html">Pharyngitis &amp; Adenotonsillar Disease</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/02/anatomy-lab-pharynx-palate.html">Pharynx &amp; Palate Anatomy Lab</a></li></ul>
				<li class="day">Thursday, April 3</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/03/neck-masses.html">Neck Masses</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/03/salivary-gland.html">Salivary Gland</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/03/head-neck-cancer.html">Head &amp; Neck Cancer</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/03/patient-cases.html">Patient Cases</a></li></ul>
				<li class="day">Friday, April 4</li>
				<ul><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/04/upper-airway-wrapup.html">Upper Airway Wrap-up Session</a></li><li class="lecture"><a href="http://kevanlu.github.io/respirology//2014/04/04/ent-small-groups.html">ENT Small Group Cases</a></li></ul>
			</ul>
		</ul>
	</div>
</nav>
    </div>
    <div class="content-offset">
        <div class="content">
             <div class="single post">
                <!-- Post Layout -->
                <div class="title"><h1>Clinical Aspects &amp; Pathology of Diffuse Interstitial Lung Diseases</h1></div>
                <info datetime="2014-03-05">
                    <span class="author"><a href="https://dl.dropboxusercontent.com/u/157117/notes-reference/jekyll/_site/contributors.html#kevanlu">Kevan Lu</a></span>
                    <span class="date">Wednesday, March 05, 2014</span>
                </info>
                <div class="body"><h2 id='lecture_outline'><strong>Lecture Outline</strong></h2>

<ul>
<li>
<p><strong>DILD</strong> = <em>Diffuse Interstitial Lung Disease</em></p>

<ul>
<li>Will see <em>diffuse infiltrates</em> on CXR.</li>
</ul>
</li>

<li>
<p>Aim to classify DILD based on etiology</p>
</li>

<li>
<p>Understand a respirologists&#8217; general approach to DILD</p>
</li>

<li>
<p>Learn and integrate the clinical, radiologic &amp; pathologic features of two common types of DILD:</p>

<ul>
<li><strong>Idiopathic pulmonary fibrosis (IPF)</strong></li>

<li><strong>Pulmonary sarcoidosis</strong></li>
</ul>
</li>
</ul>

<h2 id='restrictive_lung_disease'><strong>Restrictive Lung Disease</strong></h2>

<ul>
<li>
<p>Diffuse Interstitial Lung Diseases are a type of <strong>Restrictive Lung Disease</strong> (versus <em>Obstructive Lung Diseases</em> like COPD and Asthma).</p>
</li>

<li>
<p>Restrictive lung diseaes are split into <em>two categories</em>:</p>

<ol>
<li>
<p><strong>Parenchymal</strong> &#8594; anything in the lungs.</p>

<ul>
<li>Acute: infection, inflammation, edema, etc.</li>

<li>Subacute/<em>chronic</em>: <strong>DILD</strong>.</li>
</ul>
</li>

<li>
<p><strong>Extraparenchymal</strong> &#8594; anything outside of the lungs that&#8217;s restrictive.</p>

<ul>
<li>Kyphoscoliosis (significant), significant bilateral pleural disease, massive obesity, diaphragmatic paralysis, etc.</li>
</ul>
</li>
</ol>
</li>
</ul>

<h2 id='restrictive_vs_obstructive_lung_diseases'><strong>Restrictive vs Obstructive Lung Diseases</strong></h2>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/eex-ka79.png' />
<h2 id='findings_with_pulmonary_function_tests'><strong>Findings with Pulmonary Function Tests</strong></h2>

<ul>
<li>
<p>Will see a <em>symmetric reduction in lung volumes</em> on the <em>PFT</em>.</p>
</li>

<li>
<p>Decrease in <strong>diffusion capacity</strong> (DLCO).</p>

<ul>
<li>With <strong>parenchymal disease</strong>, there will be a <em>disproportionate decrease</em>.</li>

<li>With <strong>extraparenchymal disease</strong>, there will be a <em>proportionate decrease</em>.</li>
</ul>
</li>

<li>
<p>This makes sense &#8594; if it&#8217;s something in the lungs, you&#8217;ll see greater effects on diffusion than you would expect given the lung volume reduction.</p>
</li>

<li>
<p>Unlike obstructive diseases, you&#8217;ll see a <strong>normal FEV<sub>1</sub>/FVC</strong>.</p>
</li>
</ul>

<blockquote>
<h3 id='diagnosing_restrictive_lung_diseases'><strong>Diagnosing Restrictive Lung Diseases</strong></h3>

<ul>
<li>
<p><strong>Reduction in Lung Volumes</strong> with a <strong>normal FEV<sub>1</sub>/FVC</strong>.</p>
</li>

<li>
<p>There will be a <em>decrease in the DLCO</em></p>

<ul>
<li>In <strong>parenchymal disease</strong>, you have a <strong>disproportionate decrease</strong> in the DLCO.</li>

<li>In <strong>extraparenchymal disease</strong>, you will have a <strong>proportionate decrease</strong> in the DLCO.</li>
</ul>
</li>
</ul>
</blockquote>

<h2 id='clinical_findings_with_dild'><strong>Clinical Findings with DILD</strong></h2>

<h4 id='symptoms'><strong>Symptoms</strong></h4>

<ul>
<li><em>Gradually progressive dyspnea</em> with exercise limitation, and possible dry cough.</li>

<li>A dry, hacking, non-productive cough is a common finding.</li>

<li>The <strong>gradually progressive dyspnea</strong> is the most penetrant sign however! Patients will usually have several years of worsening SOB, especially with exercise.</li>
</ul>

<h4 id='signs'><strong>Signs</strong></h4>

<ul>
<li><em>Tachypnea</em> with <strong>dry inspiratory crackles</strong></li>

<li>At the beginning, you have to put the stethoscope at very bottom of lung and make the patient take a deep breath to hear the crackles.</li>

<li>This will slowly progress up the chest as the disease progresses.</li>

<li><strong>digital clubbing</strong> may also be seen.</li>
</ul>

<h4 id='chest_xray'><strong>Chest X-Ray</strong></h4>

<ul>
<li><strong>Reduction in lung volumes</strong> with <strong>diffuse infiltrates</strong>.</li>

<li>These diffuse infiltrates will lead to <em>end-stage fibrosis</em> that will look like <strong>honeycombs</strong> &#8594; &#8220;honeycombing&#8221;.</li>
</ul>

<h4 id='hrct'><strong>HRCT</strong></h4>

<ul>
<li><strong>HRCT</strong> = <em>High Resolution CT</em> &#8594; you can often see abnormalities on CT earlier than with a chest X-ray.</li>

<li>However, these are often <em>non-specific</em>, so even though the sensitivity may be better, the specificity is worse.</li>
</ul>

<blockquote>
<h3 id='clinical_findings_with_dild'><strong>Clinical Findings with DILD</strong></h3>

<ul>
<li><strong>Gradually progressive dyspnea</strong> with possible <em>dry, non productive cough</em>.</li>

<li><strong>Dry inspiratory crackles</strong>, and <em>tachypnea</em>.</li>

<li><strong>Lung volume reduction</strong> with <strong>diffuse infiltrates</strong> on CXR &#8594; <em>honeycombing</em>.</li>
</ul>
</blockquote>

<h2 id='etiologic_classification_of_dild'><strong>Etiologic Classification of DILD</strong></h2>

<p><strong>Restrictive Lung Diseases</strong>:</p>

<ul>
<li>
<p><strong>Parenchymal</strong></p>

<ul>
<li>
<p>Acute: infection, inflammation, edema, etc.</p>
</li>

<li>
<p>Subacute/chronic: <strong>DILD</strong>.</p>

<ul>
<li><strong>Known Etiology</strong></li>

<li><strong>Unknown Etiology</strong></li>
</ul>
</li>
</ul>
</li>

<li>
<p><strong>Extraparenchymal</strong></p>

<ul>
<li>Kyphoscoliosis (significant), significant bilateral pleural disease, massive obesity, diaphragmatic paralysis, etc.</li>
</ul>
</li>

<li>
<p>There are many different classification schemes, but one convenient one is to separate DILDs based on <em>known/unknown etiology</em>.</p>
</li>
</ul>

<h4 id='1_diseases_of_known_etiology'>1. <strong>Diseases of Known Etiology</strong></h4>

<ul>
<li>
<p>Diseases of known etiology are <strong>much less common</strong> than diseases of unknown etiology.</p>
</li>

<li>
<p>However, these can be <em>diagnosed</em>! For unknown etiology, you must make a <em>diagnosis by exclusion</em>!</p>
</li>

<li>
<p><strong>Inorganic</strong> &#8594; pneumoconioses, asbestosis</p>

<ul>
<li>Dust, metals, fibres.</li>

<li><em>Pneumoconiosis</em> is caused by dust exposure, especially in mines.</li>

<li><em>Asbestosis</em> is caused by asbestos exposure.</li>
</ul>
</li>

<li>
<p><strong>Organic</strong> &#8594; hypersensitivity pneumonitis</p>

<ul>
<li>Any living/recently-living material, that you may have become sensitive to.</li>

<li>Appropriately, this is called <em>hypersensitivity pneumonitis</em>.</li>
</ul>
</li>

<li>
<p><strong>Drugs</strong> &#8594; dose-related vs. idiosyncratic</p>

<ul>
<li>Sometimes, these are completely dependent on dose.</li>

<li>For instance, <strong>high-dosage bleomycin</strong> (we saw this in Blood).</li>

<li>Most of the time, it&#8217;s an <em>idiosyncratic reaction</em> &#8594; eg. a small subset of people taking amiodarone may develop lung scarring.</li>
</ul>
</li>

<li>
<p><strong>Other</strong> &#8594; radiation, lymphangitic carcinomatosis, etc.</p>

<ul>
<li>Radiation to the lungs.</li>

<li>Cancer spreading to the lungs.</li>
</ul>
</li>
</ul>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/tikgbv8t.png' />
<ul>
<li>
<p>The <em>big three</em> we try to ask about for <strong>Hypersensitivity pneumonitis</strong> are:</p>

<ol>
<li><strong>Bird Fanciers</strong> &#8594; eg. people who keep pigeons.</li>

<li><strong>Farmer&#8217;s Lung</strong> &#8594; typically a reaction to improperly stored grain.</li>

<li><strong>Humifier Lung</strong> &#8594; mold growing on a humidifier that hasn&#8217;t been cleaned.</li>
</ol>
</li>

<li>
<p>The <em>drugs</em> we ask about for <strong>Drug-Induced DILD</strong>.</p>

<ol>
<li><strong>Nitrofurantoin</strong> &#8594; very old <em>urinary antiseptic</em> that old women take for recurrent bladder infections. Huge source of interstitial lung disease.</li>

<li><strong>Chemotherapy</strong> &#8594; eg. <em>Bleomycin</em></li>
</ol>

<ul>
<li><strong>DMARDs</strong> &#8594; <em>Disease Modifying Agents for the Rheumatic Diseases</em>, such as <em>Methotrexate</em>, <em>Cyclosporine</em>, etc.</li>

<li><strong>Amiodarone</strong> &#8594; Antiarrythmic we saw in Heart &#38; Circulation.</li>
</ul>
</li>

<li>
<p>If one of these triggers has been seen, the obvious and easy fix is just to <em>get rid of the trigger</em>!</p>
</li>

<li>
<p>If you catch the problem soon enough, and get rid of the trigger, oftentimes the disease state can be quite reversible.</p>
</li>
</ul>

<blockquote>
<h3 id='exposure_history_for_dild'><strong>Exposure History for DILD</strong></h3>

<ul>
<li>
<p><strong>Hypersensitivity Pneumonitis</strong></p>

<ol>
<li><em>Bird-fanciers</em></li>

<li><em>Farmer&#8217;s lung</em></li>

<li><em>Humidifier Lung</em></li>
</ol>
</li>

<li>
<p><strong>Drug-induced DILD</strong></p>

<ol>
<li><em>Nitrofurantoin</em></li>

<li><em>Chemotherapy</em> &#8594; eg. Bleomycin.</li>

<li><em>DMARDS</em> &#8594; eg. Methotrexate, cyclosporine, etc.</li>

<li><em>Amiodarone</em></li>
</ol>
</li>
</ul>
</blockquote>

<h4 id='2_diseases_of_unknown_etiology'>2. <strong>Diseases of Unknown Etiology</strong></h4>

<p>To diagnose a patient with one of these, you must first <em>rule out the ones of known etiology</em>.</p>

<ol>
<li>
<p><strong>Idiopathic Interstitial Pneumonia (IIP)</strong> &#8594; the most common type of DILD.</p>

<ul>
<li>The most common form of IIP is <strong>Idiopathic Pulmonary Fibrosis (IPF)</strong>.</li>
</ul>
</li>

<li>
<p><strong>IIP with Collagen Vascular Disorders</strong> &#8594; IIP with a collagen vascular disorder as well.</p>

<ul>
<li>Dermatomyositis, MCTD, scleroderma, SLE, etc.</li>
</ul>
</li>

<li>
<p><strong>Sarcoidosis</strong> &#8594; will have many other manifestations because granulomas go everywhere.</p>
</li>

<li>
<p><strong>Miscellaneous</strong></p>

<ul>
<li>Eosinophilic granuloma, alveolar proteinosis, etc.</li>
</ul>
</li>
</ol>

<blockquote>
<h4 id='remember'><strong>Remember</strong></h4>

<ul>
<li>The most common type of DILD of unknown etiology is <em>Idiopathic Interstitial Pneumonia (IIP)</em>. The most common form of IIP is <em>Idiopathic Pulmonary Fibrosis (IPF)</em>.</li>
</ul>
</blockquote>
<hr style='border:none; margin-bottom:15px;' />
<h1 id='idiopathic_pulmonary_fibrosis_ipf'>Idiopathic Pulmonary Fibrosis (IPF)</h1>
<hr />
<h2 id='clinical_aspects_of_ipf'><strong>Clinical Aspects of IPF</strong></h2>

<h4 id='presentation'><strong>Presentation</strong></h4>

<ul>
<li>
<p>Usually middle-aged or elderly patients &#8594; it&#8217;s unusual to see a patient under the age of 50 with this condition.</p>
</li>

<li>
<p>Insidiously progressive dyspnea +/- dry cough.</p>
</li>

<li>
<p>Bibasilar inspiratory crackles +/- <em>clubbing</em>.</p>

<ul>
<li>IPF is one of the most common causes of clubbing in an adult.</li>
</ul>
</li>

<li>
<p>Will see progressive drops in lung volumes, and diffusion defects, as well as a disproportionate drop in the DLCO, as discussed previously.</p>
</li>

<li>
<p><em>Basal</em> (bases) and <em>cortical</em> (outside) regions of the lungs are affected first.</p>
</li>

<li>
<p>By definition, as we have said before, <strong>other etiologies must be ruled out</strong>.</p>
</li>
</ul>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/jp-c1ok6.png' />
<h4 id='radiology'><strong>Radiology</strong></h4>

<ul>
<li>Here, you can see a CXR showing diffuse infiltrates with that archetypical <em>honeycombed</em> pattern.</li>

<li>Note that this is more prevalent at the <em>basal</em> and <em>cortical</em> regions of the lungs, as was described before.</li>
</ul>
<span class='sidenote'>Recall that the costo-phrenic angles are the 'corners' of the lungs, where they meet the diaphragm.</span>
<ul>
<li>This patient also has blunting of the left costo-phrenic angle, but this is probably due to something else.</li>
</ul>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/nt41l341.png' />
<ul>
<li>Also, note that the lung volumes have decreased.</li>

<li>Here is advanced IPF on CT.</li>

<li>You can see cystic changes (<em>honeycombing</em>) throughout the entire bottom of the lung.</li>

<li>This CT would be conclusively IPF.</li>
</ul>

<h4 id='prognosis'><strong>Prognosis</strong></h4>

<ul>
<li>
<p>The prognosis for IPF is <em>bad</em> &#8594; as bad as some cancers.</p>
</li>

<li>
<p>Average survival is <em>4-5 years</em>, but this is quite variable.</p>
</li>

<li>
<p>Better outcomes are associated with younger age, acute insult causing the onset, or rapid progression.</p>

<ul>
<li>It&#8217;s somewhat counterintuitive that the ones that rapidly progress have better outcomes &#8594; it&#8217;s actually the <em>insidiously progressive</em> ones that generally fare more poorly.</li>
</ul>
</li>
</ul>

<h4 id='treatment'><strong>Treatment</strong></h4>

<ul>
<li>Response to high-dose corticosteroids (<strong>prednisone</strong>) is one of the <em>best prognostic indicators</em> for DILD in general.</li>

<li>For instance, <em>hypersenstivity pneumonitis</em> will respond very well to prednisone.</li>

<li>However, the most common condition, which is IPF, <em>doesn&#8217;t respond well to steroids.</em></li>

<li>So IPF is typically treated with supportive care &#8594; supplemental oxygen, etc.</li>
</ul>

<blockquote>
<h4 id='remember'><strong>Remember</strong></h4>

<ul>
<li><strong>Prednisone sensitivity</strong> is a strong <em>prognostic indicator</em> for <strong>DILD</strong>, but prednisone is not very effective with <strong>IPF</strong>.</li>
</ul>
</blockquote>
<hr />
<h2 id='pathology_of_ipf'><strong>Pathology of IPF</strong></h2>

<ul>
<li><strong>IPF</strong> is an <em>interstitial inflammatory fibrosing lung disease of unknown etiology</em>.</li>

<li>The use of pathology in diagnosing IPF and other diseases has decreased significantly due to the increasing use of imaging for diagnosis.</li>

<li><strong>Usual interstitial pneumonia (UIP)</strong> is the histological pattern of fibrosis.</li>
</ul>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/z3v-mg6s.png' />
<ul>
<li>With IPF, you will have a <strong>honeycomb lung</strong>.</li>

<li>The lung will be firm to the touch, and there will be <em>holes in the lung</em>, that will be preferentially located on the basal and cortical regions. (bottom and sides).</li>
</ul>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/vtyt9y30.png' />
<blockquote>
<h3 id='pathogenesis_of_ipf'><strong>Pathogenesis of IPF</strong></h3>

<p>There are <strong>two theories</strong> as to the <em>pathogenesis of IPF</em>:</p>

<ol>
<li>
<p><strong>Inflammatory Fibrosis Theory</strong> &#8594; the <em>prevailing hypothesis</em>.</p>

<ul>
<li><em>Inflammation leads to fibrosis</em>.</li>
</ul>
</li>

<li>
<p><strong>Abnormal Wound Healing Model</strong> &#8594; this is the <em>modern theory</em>, and is still evolving.</p>

<ul>
<li><em>Epithelial injury leads to fibrosis</em>.</li>
</ul>
</li>
</ol>
</blockquote>

<h4 id='1_the_inflammatory_fibrosis_theory'>1. <strong>The Inflammatory Fibrosis Theory</strong></h4>

<ol>
<li>
<p><strong>Alveolitis</strong></p>

<ul>
<li>Normally, we have <strong>Type I cells</strong> (flat) that line the alveolar walls, and <strong>Type II cells</strong> that produce surfactant.</li>

<li>Within the airspace, there are usually only a few macrophages.</li>

<li>When there is <em>alveolitis</em>, there is an accumulation of inflammatory cells <em>within the airspace</em> &#8594; macrophages and neutrophils.</li>

<li>In IPF, this accumulation is due to unknown reasons.</li>

<li>These lead to the release of cytokines.</li>
</ul>
</li>

<li>
<p><strong>Parenchymal &#38; Connective Tissue Alteration</strong></p>

<ul>
<li>Mediators released by the inflammatory cells cause alterations in the parenchyma and connective tissue.</li>
</ul>
</li>

<li>
<p><strong>Fibrosis</strong></p>
</li>

<li>
<p><strong>Honeycombing</strong></p>
</li>
</ol>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/bkfvkj0v.png' />
<ul>
<li>Because the prevailing theory is that IPF is mediated by <em>inflammation</em>, the prevailing treatment has been <strong>steroids</strong> (eg. prednisone).</li>

<li>Recently, because of the increasing popularity of the abnormal wound-healing model, there have been <em>changes</em> to this thought.</li>
</ul>

<h4 id='2_the_abnormal_wound_healing_theory'>2. <strong>The Abnormal Wound Healing Theory</strong></h4>

<p>This is the more <em>modern theory</em> as to the etiology of IPF.</p>

<ol>
<li>
<p><strong>Multiple micro-injuries</strong> (unknown cause)</p>
</li>

<li>
<p><strong>Alveolar epithelial cell damage and activation</strong></p>

<ul>
<li>This is the <em>primary event</em>.</li>

<li>Fibroblast migration and proliferation occurs, causing a phenotypic change to the myofibroblasts.</li>
</ul>
</li>

<li>
<p><strong>Basement membrane disruption and angiogenesis</strong></p>
</li>

<li>
<p><strong>Absent of delayed apoptosis and re-epithelialization</strong></p>
</li>

<li>
<p><strong>Fibrosis &#38; Honeycombing</strong></p>
</li>
</ol>

<ul>
<li>Note that here, we have <em>no inflammatory cells</em>.</li>

<li>In the context of the abnormal wound-healing model, the treatment would be focused on adressing <em>alveolar epithelial cell damage</em></li>
</ul>

<h3 id='when_to_biopsy'><strong>When to Biopsy?</strong></h3>

<ul>
<li>IPF can be clinically diagnosed with a high degree of certainty &#8594; <em>80-90% of the time</em>.</li>

<li>In patients with atypical symptoms or radiological features, definitive diagnosis is by <em>surgical lung biopsy</em> (Gold Standard).</li>
</ul>

<h3 id='pathology_of_ipf'><strong>Pathology of IPF</strong></h3>

<ul>
<li><strong>Usual Interstitial Pneumonia (UIP)</strong> describes the spectrum of features we would see in IPF, and other fibrotic lung diseases.</li>

<li><em>Location</em>: bilateral, lower lobes, sub-pleural/peripheral.</li>

<li>Patchy, heterogeneous inflammatory/fibrosing interstitial process.</li>

<li>This patchwork means that <em>some parts of the lung will be normal, and some will be abnormal</em>.</li>

<li><em>Honeycombing will be present</em></li>
</ul>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/b90mrplj.png' />
<p><code>Here we see histological images of the heterogeneous pattern of normal and fibrotic alveoli with UIP.</code></p>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/k7_v941k.png' />
<p><code>Late stage IPF on autopsy. The patient died of complications following cor pulmonale secondary to their IPF.</code></p>

<h1 id='sarcoidosis'>Sarcoidosis</h1>
<hr />
<h2 id='clinical_aspects_of_sarcoidosis'><strong>Clinical Aspects of Sarcoidosis</strong></h2>

<h4 id='presentation'><strong>Presentation</strong></h4>

<ul>
<li>
<p>Constitutional complaints very common</p>

<ul>
<li>Anorexia, malaise, low grade fever, etc.</li>

<li>Often very similar to a flu-like illness.</li>

<li>We suspect that many people get this disease acutely, and then get better. The cases of sarcoidosis we see are the small subset of people that do not get better.</li>
</ul>
</li>

<li>
<p>The <strong>thorax is involved in &#62;90% of cases</strong> but chest exam may be normal!</p>
</li>

<li>
<p>Associated splenomegaly &#38; peripheral lymphadenopathy is common.</p>
</li>

<li>
<p>Can present to any sub-specialist!</p>
</li>

<li>
<p>Presents in <em>much younger populations</em> compared to other fibrotic lung disorders.</p>
</li>
</ul>

<h4 id='pulmonary_features_of_sarcoidosis'><strong>Pulmonary Features of Sarcoidosis</strong></h4>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/06o86fmd.png' />
<ul>
<li>
<p><strong>Lofgren&#8217;s Syndrome</strong> &#8594; <em>most common, but the least worrisome</em>.</p>

<ul>
<li><strong>Erythema nodosum</strong> &#8594; raised red rash, typically on the shins.</li>

<li>Classic presentation &#8594; if you see a young patient who presents with a rash like this that has been tender for the past few weeks, the next order is typically a CXR.</li>

<li>If you see <strong>bilateral hilar lympadenopathy (BHL)</strong>, as well, then it&#8217;s sarcoidosis.</li>
</ul>
</li>

<li>
<p>Most patients like this will get better with no treatment over time. Sometimes, we give them NSAIDs to reduce pain.</p>
</li>

<li>
<p>We tend to get involved in patients that progress more, and have <em>DILD</em>, with the classic <em>progressive dyspnea</em></p>

<ul>
<li>They will have characteristic radiographic findings that will separate them from IPF.</li>

<li>For instance, if fibrosis occurs with <em>Sarcoidosis</em>, it&#8217;ll generally be in the <strong>upper lung zones</strong>.</li>

<li>There will also be multiple <em>extrapulmonary manifestations</em>.</li>
</ul>
</li>
</ul>

<blockquote>
<h4 id='remember'><strong>Remember</strong></h4>

<ul>
<li><strong>Lofgren&#8217;s Syndrome</strong> = <strong>Erythema nodosum</strong> + <strong>Bilateral Hilar Lympadenopathy</strong>.</li>
</ul>
</blockquote>

<blockquote>
<h4 id='remember'><strong>Remember</strong></h4>

<ul>
<li>Fibrosis due to <strong>sarcoidosis</strong> &#8594; <strong>upper lung zones</strong>.</li>

<li>Fibrosis due to <strong>IPF</strong> &#8594; <strong>basal and cortical regions</strong>.</li>
</ul>
</blockquote>

<h4 id='extrapulmonary_features_of_sarcoidosis'><strong>Extrapulmonary Features of Sarcoidosis</strong></h4>

<ul>
<li>
<p><strong>Skin</strong></p>

<ul>
<li><em>Erythema nodosum</em> &#8594; just a nuisance.</li>

<li><em>Lupus pernio</em> &#8594; invasive and disfiguring.</li>
</ul>
</li>

<li>
<p><strong>Eye</strong> &#8594; <strong>uveitis</strong>, which can make you <em>blind</em></p>

<ul>
<li>Uveitis is where you have inflammation the uvea.</li>

<li>It must be treated promptly with steroids.</li>
</ul>
</li>

<li>
<p><strong>Hypercalcemia</strong></p>
</li>

<li>
<p><strong>Liver</strong> &#8594; <em>Granulomatous hepatitis</em>.</p>

<ul>
<li>Almost always involved, but usually not damaged.</li>

<li>This makes it a very useful place to take a biopsy to look for <strong>non-caseating granulomas</strong> &#8594; pathognomonic for sarcoidosis!</li>
</ul>
</li>

<li>
<p><strong>Joints</strong> &#8594; <em>Peripheral pauci-articular arthritis</em></p>

<ul>
<li>This means that you&#8217;ll have arthritis a <em>few joints at a time</em>.</li>
</ul>
</li>

<li>
<p><strong>Cardiac</strong> &#8594; esp. arrhythmias, heart block</p>

<ul>
<li>These are very serious, and are rarely seen.</li>

<li>This seems to be more common in black patients.</li>
</ul>
</li>

<li>
<p><strong>CNS</strong> &#8594; cranial neuropathies, brainstem infiltrates</p>

<ul>
<li>These are also very serious.</li>
</ul>
</li>
</ul>

<blockquote>
<h4 id='remember'><strong>Remember</strong></h4>

<p><strong>Non-caseating granulomas</strong> = <strong>Sarcoidosis</strong></p>
</blockquote>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/4ip6on-q.png' /><p><code><b>Erythema nodosum</b> involves the subcutaneous tissue, so panniculitus (inflammation of the subcutaneous fat) occurs. These are actually not due to the formation of granulomas &rarr; erythema nodosum can appear in many other diseases. On the other hand, <b>lupus pernio</b> is due to sarcoidal granulas in the dermis.</code></p>
<h4 id='radiographic_stages_in_sarcoidosis'><strong>Radiographic Stages in Sarcoidosis</strong></h4>

<ul>
<li>
<p>This is a bit of a <em>misnomer</em> &#8594; stages suggest progression from one stage to the next, but this isn&#8217;t true in this case.</p>
</li>

<li>
<p>This refers to a <em>radiographic classification</em>, not a physiological progression.</p>

<ol>
<li><strong>Stage 1</strong> &#8594; Bilateral hilar &#38; mediastinal lympadenopathy with no infiltrates.</li>

<li><strong>Stage 2</strong> &#8594; BHL + lung infiltrates.</li>

<li><strong>Stage 3</strong> &#8594; lung infiltrates only.</li>

<li><strong>(Stage 4)</strong> &#8594; end-stage upper lobe fibrosis. Only sometimes mentioned.</li>
</ol>
</li>
</ul>

<blockquote>
<h3 id='radiographic_stages_in_sarcoidosis'><strong>Radiographic Stages in Sarcoidosis</strong></h3>

<ul>
<li><em>Stage I</em> &#8594; lympadenopathy only.</li>

<li><em>Stage II</em> &#8594; lympadenopathy + pulmonary infiltrates</li>

<li><em>Stage III</em> &#8594; pulmonary infiltrates only.</li>

<li><em>Stage IV</em> &#8594; upper-lobe fibrosis.</li>
</ul>
</blockquote>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/-4g8kwre.png' />
<ul>
<li>This is a CXR of a <em>Stage I</em> Sarcoidosis.</li>

<li>We shouldn&#8217;t have the curved opacity above the left-heart border.</li>

<li>This is suggestive of mediastinal lymphadenopathy.</li>

<li>We also see hilar lympadenopathy because the region where the pulmonary artery should be is too big.</li>

<li>This takes some experience to see!</li>
</ul>

<h4 id='lab_abnormalities'><strong>Lab Abnormalities</strong></h4>

<ul>
<li>
<p><strong>Common</strong> &#8594; mild elevation of <em>liver enzymes</em> (since the liver is often involved).</p>

<ul>
<li><strong>Hypergammaglobinemia</strong> because the immune system is turned one.</li>

<li><em>Sarcoid granulomas</em> actually produce <strong>angiotensin-converting enzyme (ACE)</strong>!</li>
</ul>
</li>

<li>
<p><strong>Uncommon</strong> &#8594; hypercalciuria, hypercalcemia.</p>

<ul>
<li>Activated 1a-hydroxylase &#8594; converts inactive to active vitamin D.</li>

<li>If you have hypercalcemia with no obvious cause, you would have sarcoidosis in your DDx, especially since it&#8217;s iminently treatable.</li>
</ul>
</li>
</ul>

<h4 id='prognosis'><strong>Prognosis</strong></h4>

<ul>
<li>Majory of patients are <em>asymptomatic</em> or have <em>self-limited disease</em> that requires no treatment.</li>

<li>Less than 10% actually require Rx. for severe symptoms and/or life threatening disease.</li>
</ul>

<h4 id='treatment'><strong>Treatment</strong></h4>

<ul>
<li>
<p>Treatment must be individualized to the patient, presentation, and disease severity.</p>
</li>

<li>
<p>Typically we use <strong>non-steroidal anti-inflammatory therapy</strong>.</p>
</li>

<li>
<p><strong>Prednisone</strong> is used for severe symptoms or major organ involvement</p>

<ul>
<li>must treat <em>uveitis</em>, <em>hypercalcemia</em> &amp; <em>CNS or cardiac involvement</em>.</li>

<li>The role of steroids in various types/stages of <em>lung involvement</em> is less clear. It may delay it, but doesn&#8217;t prevent it.</li>
</ul>
</li>
</ul>

<blockquote>
<h3 id='treatment_of_sarcoidosis'><strong>Treatment of Sarcoidosis</strong></h3>

<ul>
<li>
<p>Typically, <strong>NSAIDS</strong> are used.</p>
</li>

<li>
<p>For patients with severe symptoms/end organ involvement, <strong>Prednisone</strong> is used.</p>
</li>

<li>
<p><em>You must use prednisone with:</em></p>

<ol>
<li><strong>Uveitis</strong></li>

<li><strong>Hypercalcemia</strong></li>

<li><strong>CNS or Cardiac involvement</strong></li>
</ol>
</li>
</ul>
</blockquote>
<hr />
<h2 id='pathology_of_sarcoidosis'><strong>Pathology of Sarcoidosis</strong></h2>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/56rub5p5.png' />
<ul>
<li><em>Sarcoidosis</em> is a <em>multisystem disease</em> of unknown etiology characterized by <strong>non-caseating granulomas</strong> in many organs.</li>

<li>It&#8217;s <em>more common</em> than IPF, presents in younger populations, and is <em>more treatable</em>. (IPF has a much poorer prognosis)</li>

<li>Unlike IPF, <i>pathology plays a big role in the diagnosis of sarcoidosis.</i></li>
</ul>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/p0imy66j.png' />
<ul>
<li>The mediastinal and hilar lymph nodes are most commonly affected.</li>

<li>These nodes, along with the lungs, are the major regions where sarcoidosis is involved.</li>

<li>Lymphadenopathy will often be seen before diffuse infiltrates, as we saw previously with our radiographic staging of Sarcoidosis.</li>

<li>The uveal tract is affected sometimes as well (<em>uveitis</em>)</li>
</ul>

<blockquote>
<h3 id='pathogenesis_of_sarcoidosis'><strong>Pathogenesis of Sarcoidosis</strong></h3>

<ul>
<li>
<p>Sarcoidosis is a disease of <strong>disordered immune regulation</strong></p>
</li>

<li>
<p>The current thinking is that <em>three events are needed</em>:</p>

<ol>
<li>Exposure to <em>some kind of antigen</em> (antigen still not yet known).</li>

<li>Acquired cell-mediated <em>T-cell response</em>.</li>

<li>CD4+ T-helper cells drive a chronic immunologic response &#8594; <em>granulomas</em></li>
</ol>
</li>

<li>
<p>We suspect there is some degree of genetic susceptibility, due to familial and racial differences in incidence.</p>
</li>
</ul>
</blockquote>

<h4 id='pathological_features_of_sarcoidosis'><strong>Pathological Features of Sarcoidosis</strong></h4>

<ul>
<li>
<p><em>T-helper cells increased at tissue level</em></p>

<ul>
<li>CD4+/CD8+ ratio = <em>10:1</em></li>
</ul>
</li>

<li>
<p><em>T-helper cells decreased in peripheral blood</em></p>

<ul>
<li>CD4+/CD8+ ratio = <em>0.8:1</em> (normal 2:1)</li>
</ul>
</li>

<li>
<p>T-helper cells in tissue assist in formation of granulomas (through cytokines and macrophage activation).</p>
</li>

<li>
<p>Granulomas produce <strong>angiotensin converting enzyme</strong> (ACE, Lab test).</p>
</li>

<li>
<p>There is <strong>Polyclonal hypergammaglobulinemia</strong> due to T-helper cell dysregulation.</p>
</li>
</ul>

<h4 id='the_role_of_biopsy'><strong>The role of Biopsy</strong></h4>

<ul>
<li>
<p>Sarcoidosis is a <strong>clinicopathologic diagnosis</strong>.</p>
</li>

<li>
<p>So a <em>biopsy is essential for diagnosis</em>.</p>

<ul>
<li>The most common type of biopsy is a transbronchial lung biopsy.</li>

<li>Sometimes we do a mediastinoscopy, with a mini-thoracotomy, and a mediastinal scope. This is done less often because it&#8217;s more invasive.</li>

<li>Lymph node biopsies, liver core biopsies, salivary gland biopsies, etc, can also be done, depending on which tissues are involved.</li>
</ul>
</li>
</ul>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/6bswbjm0.png' />
<h4 id='noncaseating_granulomas'><strong>Non-Caseating Granulomas</strong></h4>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/8kz3t5y8.png' />
<ul>
<li><strong>Granuloma</strong> = <em>collection of inflammatory cells</em></li>

<li>Macrophages become <em>Epitheloid Cells</em> (1).</li>

<li>These can join together to become <em>Multinucleated Giant Cells</em> (2).</li>

<li><strong>CD4+ T-helper cells</strong> will be present in the centre (3), and help in forming the granuloma.</li>

<li>Some <strong>CD8+ cells</strong> and <strong>B cells</strong> will be seen on the periphery (4)</li>

<li><strong>non-caseating</strong> = <em>no necrosis in the centre of the granuloma</em>.</li>
</ul>

<h4 id='distribution_of_granulomas_in_sarcoidosis'><strong>Distribution of Granulomas in Sarcoidosis</strong></h4>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/yxeew7sz.png' />
<ul>
<li>
<p>Granulomas will be located near the <em>bronchovascular bundles</em>, in the <em>interlobular septa</em>, and in the <em>subpleural region</em>.</p>

<ul>
<li>This pattern of distribution is known as a <strong>lymphatic pattern</strong>, with respect to the lung interstitium.</li>

<li>This is why <em>transbronchial biopsies</em> are so effective in diagnosing sarcoidosis &#8594; there will generally be non-caseating granulomas near the bronchovascular bundles.</li>
</ul>
</li>

<li>
<p>Granulomas will resolve via <em>fibrosis</em>.</p>
</li>

<li>
<p>Depending on the density of the granulomas, <strong>interstitial fibrosis</strong> and <em>honeycombing</em> may occur (in 5-15% of cases).</p>
</li>
</ul>

<h4 id='differential_for_sarcoidosis'><strong>Differential for Sarcoidosis</strong></h4>

<ul>
<li>
<p><em>Infection</em></p>

<ul>
<li>Mycobacterial &#8594; <strong>Tuberculosis</strong></li>

<li>Fungal</li>
</ul>
</li>

<li>
<p><em>Berylliosis</em> &#8594; beryllium exposure can also produce a granulomatous reaction.</p>
</li>

<li>
<p>We usually do an <em>acid fast</em> and <em>fungal stain</em> on tissue, before we suggest the diagnosis of sarcoidosis in a biopsy (eliminate mycobacterial and funal etiologies).</p>
</li>
</ul>

<h1 id='hypersensitivity_pneumonitis'>Hypersensitivity Pneumonitis</h1>
<hr />
<ul>
<li><strong>Hypersensitivity pneumonitis</strong> is more accurately referred to as <strong>extrinsic allergic alveolitis</strong>.</li>

<li>It&#8217;s a complex pulmonary immune response to an inhaled organic antigen.</li>

<li>The onset may be insidious with delayed symptoms.</li>

<li>Thousands of exposures have been incrimated.</li>

<li>As we&#8217;ve said before, the <strong>big three</strong> are:</li>
</ul>

<blockquote>
<h4 id='hypersensitivity_pneumonitis'><strong>Hypersensitivity Pneumonitis</strong></h4>

<ol>
<li><em>Bird-fanciers</em></li>

<li><em>Farmer&#8217;s lung</em></li>

<li><em>Humidifier Lung</em></li>
</ol>
</blockquote>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/5l18c74q.png' />
<p><code>All kinds of things can cause hypersensitivity pneumonitis!</code></p>

<h4 id='diagnosing_hypersensitivity_pneumonitis'><strong>Diagnosing Hypersensitivity Pneumonitis</strong></h4>

<ul>
<li>
<p>Careful exposure history (work, hobbies, travel)</p>
</li>

<li>
<p>Can measure circulating antibodies to known antigens. However, this is <em>non-specific</em></p>

<ul>
<li>If you see antibodies expected in farmer&#8217;s lung, all that&#8217;ll tell you is that the patient is a farmer!</li>

<li>But with CXR results, and symptoms, this is more helpful!</li>
</ul>
</li>

<li>
<p>We rarely do a controlled exposure, because the immune response can be pretty serious.</p>
</li>
</ul>

<h4 id='treatment'><strong>Treatment</strong></h4>

<ul>
<li><strong>Avoidance</strong>!</li>

<li>In cases where there is severe disease, <em>steroids</em> may be used.</li>
</ul>

<h1 id='drug_induced_dild'>Drug Induced DILD</h1>
<hr />
<ul>
<li>Reactions can be acute, but can also be delayed or even insidious (especially with chronic treatment).</li>

<li>We can have <em>dose-related</em> toxicity (<strong>bleomycin</strong>) or an <em>idiosyncratic</em> reaction (<strong>amiodarone</strong>).</li>
</ul>

<blockquote>
<h4 id='druginduced_dild'><strong>Drug-induced DILD</strong></h4>

<ol>
<li><em>Nitrofurantoin</em></li>

<li><em>Chemotherapy</em> &#8594; eg. Bleomycin.</li>

<li><em>DMARDS</em> &#8594; eg. Gold, methotrexate, sulfasalazine, etc.</li>

<li><em>Amiodarone</em></li>
</ol>
</blockquote>

<h1 id='pneumoconiosis'>Pneumoconiosis</h1>
<hr /><img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/xz10q7qa.png' />
<ul>
<li>
<p><strong>Asbestosis</strong> = <em>interstitial lung disease due to asbestos</em>.</p>
</li>

<li>
<p>But asbestos can cause other things &#8594; pleural plaques (thickening and calcification of the pleural surface).</p>
</li>

<li>
<p>With <em>Asbestos exposure</em>, we have different presentations depending on the dose-response and latency.</p>

<ul>
<li>Short latency: <strong>pleural effusion</strong>.</li>

<li>High dose: <strong>asbestosis</strong>.</li>

<li>Low dose &#38; long latency: <strong>mesothelioma</strong>.</li>
</ul>
</li>

<li>
<p>The problem with asbestos related diseases is that the exposure invariably happens a long time ago, which makes taking the history difficult.</p>
</li>
</ul>                
                </div>
            </div>
            <div class="pagination">
                <div class="four columns" style="margin:0; padding:0; float:left;">
                     
                        <a class="newer" href="http://kevanlu.github.io/respirology//2014/03/05/cough-wheeze-child-small-group.html">Cough &amp; Wheeze Pediatric Small Group</a> 
                     
                </div>
                <div class="four columns" style="margin:0; padding:0; float:right;">
                     
                        <a class="older" href="http://kevanlu.github.io/respirology//2014/03/06/respiratory-medicine-small-group.html">Respirology Small Group Cases 7-10</a> 
                     
                </div>
            </div>
        </div>
    </div>
    <script src="http://kevanlu.github.io/respirology//index.js" type="text/javascript"></script>
<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/tipuesearch.css">	
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch_set.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch.js" type="text/javascript"></script>

<script>
$(document).ready(function() {
     $('#tipue_search_input').tipuesearch();
});
</script>
</body>
</html>